OTCMKTS:BAYRY Bayer Aktiengesellschaft (BAYRY) Stock Price, News & Analysis $15.63 -0.04 (-0.25%) As of 11:24 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsNews and TrendsSEC FilingsShort Interest About Bayer Aktiengesellschaft Stock (OTCMKTS:BAYRY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BAYRY alerts:Sign Up Key Stats Today's Range$15.60▼$15.7250-Day Range$12.07▼$15.9852-Week Range$7.65▼$15.98Volume105,344 shsAverage Volume1.07 million shsMarket Capitalization$61.43 billionP/E RatioN/ADividend Yield0.13%Price TargetN/AConsensus RatingBuy Company Overview Bayer Aktiengesellschaft is a German life sciences company headquartered in Leverkusen. Founded in 1863, it develops products and services in pharmaceuticals, consumer health and agriculture. Its Pharmaceuticals business offers prescription medicines, including treatments in areas such as cardiovascular disease, oncology, women’s health and eye care. Consumer Health sells nonprescription medicines and self-care products, with brands including Claritin, Aleve and One A Day. Through its Crop Science business, Bayer provides seeds, crop protection products and agricultural solutions for farmers. The company serves customers in markets around the world.AI Generated. May Contain Errors. Read More Bayer Aktiengesellschaft Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks53rd Percentile Overall ScoreBAYRY MarketRank™: 2.63475409836 of 5 starsBayer Aktiengesellschaft scored higher than 53% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.6 / 5Analyst RatingBuy Consensus RatingBayer Aktiengesellschaft has received a consensus rating of Buy. The company's average rating score is 3.13, and is based on 2 strong buy ratings, 5 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageBayer Aktiengesellschaft has received no research coverage in the past 90 days.Read more about Bayer Aktiengesellschaft's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth4.69% Earnings GrowthEarnings for Bayer Aktiengesellschaft are expected to grow by 4.69% in the coming year, from $1.28 to $1.34 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Bayer Aktiengesellschaft is 11.81, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.74.Price to Earnings Ratio vs. SectorThe P/E ratio of Bayer Aktiengesellschaft is 11.81, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 35.36.Price to Earnings Growth RatioBayer Aktiengesellschaft has a PEG Ratio of 2.00. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBayer Aktiengesellschaft has a P/B Ratio of 2.09. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of Bayer Aktiengesellschaft has been sold short.Short Interest Ratio / Days to CoverBayer Aktiengesellschaft has a short interest ratio ("days to cover") of 0.12, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Bayer Aktiengesellschaft has recently decreased by 64.07%, indicating that investor sentiment is improving significantly. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldBayer Aktiengesellschaft has a dividend yield of 0.15%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBayer Aktiengesellschaft does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Bayer Aktiengesellschaft will have a dividend payout ratio of 1.49% next year. This indicates that Bayer Aktiengesellschaft will be able to sustain or increase its dividend.Read more about Bayer Aktiengesellschaft's dividend. News and Social Media2.2 / 5News Sentiment0.50 News SentimentBayer Aktiengesellschaft has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Bayer Aktiengesellschaft this week, compared to 4 articles on an average week.Search InterestOnly 5 people have searched for BAYRY on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows1 people have added Bayer Aktiengesellschaft to their MarketBeat watchlist in the last 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Bayer Aktiengesellschaft insiders have not sold or bought any company stock.Percentage Held by InstitutionsBayer Aktiengesellschaft has minimal institutional ownership at this time.Read more about Bayer Aktiengesellschaft's insider trading history. Receive BAYRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BAYRY Stock News HeadlinesBayer Advances Elinzanetant Formulation Study as Menopause Market Competition BuildsNovember 12 at 11:51 AM | tipranks.comBayer's SUNHARBO® (asundexian), 50 mg tablets, the First and Only Factor XIa Inhibitor, Approved by the U.S.November 9, 2026 | businesswire.comA little-known law has been quietly applied to your savings for years.Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution, Cede and Company, not the individual investor. If a brokerage collapses and customer securities were pledged as collateral, secured creditors can legally come before account holders. Physical gold held in a self-directed IRA is registered directly to you, with no clearinghouse or central institution holding its title.November 13 at 1:00 AM | Monetary Gold (Ad)DZ BANK AG Keeps Their Buy Rating on Bayer (0P6S)November 7, 2026 | theglobeandmail.comBayer seeks bigger role in fast-growing Latin American biologicals marketNovember 4, 2026 | reuters.comBayer Earnings Call Signals Growth Amid Ongoing RisksNovember 3, 2026 | tipranks.comBayer to Present New Cardiovascular, Kidney and Stroke Data at the 2026 American Heart Association (AHA) Scientific SessionsNovember 3, 2026 | businesswire.comBayer AG: Solid Q3 Earnings, But Still A 'Prove-It' StoryNovember 3, 2026 | seekingalpha.comSee More Headlines BAYRY Stock Analysis - Frequently Asked Questions How have BAYRY shares performed this year? Bayer Aktiengesellschaft's stock was trading at $10.82 at the start of the year. Since then, BAYRY stock has increased by 44.8% and is now trading at $15.67. How were Bayer Aktiengesellschaft's earnings last quarter? Bayer Aktiengesellschaft (OTCMKTS:BAYRY) issued its quarterly earnings data on Tuesday, November, 3rd. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by $0.02. The business earned $11.25 billion during the quarter, compared to analysts' expectations of $11.21 billion. Bayer Aktiengesellschaft had a negative net margin of 3.12% and a positive trailing twelve-month return on equity of 16.10%. Does Bayer Aktiengesellschaft have any subsidiaries? Bayer Aktiengesellschaft subsidiaries include Asklepios BioPharmaceutical, Care/of, KaNDy Therapeutics, BlueRock Therapeutics, Monsanto Company, Zoner.ag, Dihon Pharmaceutical, and more. How do I buy shares of Bayer Aktiengesellschaft? Shares of BAYRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Bayer Aktiengesellschaft own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bayer Aktiengesellschaft investors own include Pfizer (PFE), NVIDIA (NVDA), ExxonMobil (XOM), Tesla (TSLA), Verizon Communications (VZ), Walt Disney (DIS) and Alibaba Group (BABA). Company Calendar Last Earnings11/03/2026Today11/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:BAYRY CIK1144145 Webwww.bayer.com Phone49214301Fax49-21-4306-6328Employees88,078Year Founded1863Profitability EPS (Trailing Twelve Months)($0.46) Trailing P/E RatioN/A Forward P/E Ratio11.66 P/E Growth2Net Income-$4.10 billion Net Margins-3.12% Pretax Margin-2.10% Return on Equity16.10% Return on Assets4.27% Debt Debt-to-Equity Ratio1.05 Current Ratio1.04 Quick Ratio0.67 Sales & Book Value Annual Sales$51.55 billion Price / Sales1.19 Cash Flow$2.14 per share Price / Cash Flow7.30 Book Value$7.50 per share Price / Book2.08Miscellaneous Outstanding Shares3,930,000,000Free FloatN/AMarket Cap$61.43 billion OptionableNot Optionable Beta0.57 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (OTCMKTS:BAYRY) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredTrump compared today's market to 1929President Trump warned of a 1929-style depression if Democrats won control of Congress. On November 3, they di...USA Capital Gold | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bayer Aktiengesellschaft Please log in to your account or sign up in order to add this asset to your watchlist. Share Bayer Aktiengesellschaft With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
